vidarabine phosphate has been researched along with Minimal Disease, Residual in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bénichou, J; Cazin, B; Delmer, A; Divine, M; Dreyfus, B; Dumontet, C; Eghbali, H; Feugier, P; Grosbois, B; Guibon, O; Jaubert, J; Leleu, X; Leporrier, M; Leprêtre, S; Mahé, B; Maloisel, F; Maloum, K; Tournilhac, O; Travade, P | 1 |
1 trial(s) available for vidarabine phosphate and Minimal Disease, Residual
Article | Year |
---|---|
High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia.
Topics: Adult; Aged; Biomarkers; Creatinine; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Flow Cytometry; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm, Residual; Remission Induction; Survival Rate; Treatment Outcome; Vidarabine Phosphate | 2008 |